The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study
Open accessAbstract
BACKGROUND: Selection of candidates for lung cancer screening based on individual risk has been proposed as an alternative to criteria based on age and cumulative smoking exposure (pack-years). Nine previously established risk models were assessed for their ability to identify those most likely to develop or die from lung cancer. All models considered age and various aspects of smoking exposure (smoking status, smoking duration, cigarettes per day, pack-years smoked, time since smoking cessation) as risk predictors. In addition, some models considered factors such as gender, race, ethnicity, education, body mass index, chronic obstructive pulmonary disease, emphysema, personal history of cancer, personal history of pneumonia, and family history of lung cancer. METHODS AND FINDINGS: Retrospective analyses were performed on 53,452 National Lung Screening Trial (NLST) participants (1,925 lung cancer cases and 884 lung cancer deaths) and 80,672 Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) ever-smoking participants (1,463 lung cancer cases and 915 lung cancer deaths). Six-year lung cancer incidence and mortality risk predictions were assessed for (1) calibration (graphically) by comparing the agreement between the predicted and the observed risks, (2) discrimination (area under the receiver operating characteristic curve [AUC]) between individuals with and without lung cancer (death), and (3) clinical usefulness (net benefit in decision curve analysis) by identifying risk thresholds at which applying risk-based eligibility would improve lung cancer screening efficacy. To further assess performance, risk model sensitivities and specificities in the PLCO were compared to those based on the NLST eligibility criteria. Calibration was satisfactory, but discrimination ranged widely (AUCs from 0.61 to 0.81). The models outperformed the NLST eligibility criteria over a substantial range of risk thresholds in decision curve analysis, with a higher sensitivity for all models and a slightly higher specificity for some models. The PLCOm2012, Bach, and Two-Stage Clonal Expansion incidence models had the best overall performance, with AUCs >0.68 in the NLST and >0.77 in the PLCO. These three models had the highest sensitivity and specificity for predicting 6-y lung cancer incidence in the PLCO chest radiography arm, with sensitivities >79.8% and specificities >62.3%. In contrast, the NLST eligibility criteria yielded a sensitivity of 71.4% and a specificity of 62.2%. Limitations of this study include the lack of identification of optimal risk thresholds, as this requires additional information on the long-term benefits (e.g., life-years gained and mortality reduction) and harms (e.g., overdiagnosis) of risk-based screening strategies using these models. In addition, information on some predictor variables included in the risk prediction models was not available. CONCLUSIONS: Selection of individuals for lung cancer screening using individual risk is superior to selection criteria based on age and pack-years alone. The benefits, harms, and feasibility of implementing lung cancer screening policies based on risk prediction models should be assessed and compared with those of current recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Self-citationReduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Decision curve analysis: a novel method for evaluating prediction models
Vickers, A. J., & Elkin, E. B. (2006) · Medical Decision Making · doi:10.1177/0272989x06295361 · Cited by 6,341
(2010) · University of Twente Research Information · Cited by 6,037
Moons, K. G. M., Altman, D. G., Reitsma, J. B., Ioannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, G. S. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0698 · Cited by 5,147
Self-citationClinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
Self-citationAntlanger, M., Aschauer, S., Kopecky, C., Hecking, M., Kovarik, J. J., Werzowa, J., Mascherbauer, J., Genser, B., Säemann, M. D., & Bonderman, D. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000473868 · Cited by 2,808
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Dichotomizing continuous predictors in multiple regression: a bad idea
Royston, P., Altman, D. G., & Sauerbrei, W. (2006) · Statistics in Medicine · doi:10.1002/sim.2331 · Cited by 2,312
Towards better clinical prediction models: seven steps for development and an ABCD for validation
Steyerberg, E. W., & Vergouwe, Y. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu207 · Cited by 1,928
Self-citationSteyerberg, E. W. (2009) · Statistics for Biology and Health · doi:10.1007/978-0-387-77244-8 · Cited by 1,491
Self-citationPrognosis and prognostic research: validating a prognostic model
Altman, D. G., Vergouwe, Y., Royston, P., & Moons, K. G. M. (2009) · BMJ · doi:10.1136/bmj.b605 · Cited by 1,436
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
McWilliams, A., Tammemagi, M. C., Mayo, J. R., Roberts, H., Liu, G., Soghrati, K., Yasufuku, K., Martel, S., Laberge, F., Gingras, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214726 · Cited by 1,414
Vickers, A. J., Cronin, A. M., Elkin, E. B., & Gonen, M. (2008) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-8-53 · Cited by 1,369
The National Lung Screening Trial: Overview and Study Design
National Lung Screening Trial Research Team (2011) · Radiology · doi:10.1148/radiol.10091808 · Cited by 1,274
50-Year Trends in Smoking-Related Mortality in the United States
Thun, M. J., Carter, B. D., Feskanich, D., Freedman, N. D., Prentice, R., Lopez, A. D., Hartge, P., & Gapstur, S. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1211127 · Cited by 1,177
Prognosis and prognostic research: Developing a prognostic model
Royston, P., Moons, K. G. M., Altman, D. G., & Vergouwe, Y. (2009) · BMJ · doi:10.1136/bmj.b604 · Cited by 1,172
Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
Prorok, P. C., Andriole, G. L., Bresalier, R. S., Buys, S. S., Chia, D., David Crawford, E., Fogel, R., Gelmann, E. P., Gilbert, F., Hasson, M. A., et al. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00098-2 · Cited by 1,037
Selection Criteria for Lung-Cancer Screening
Tammemägi, M. C., Katki, H. A., Hocking, W. G., Church, T. R., Caporaso, N., Kvale, P. A., Chaturvedi, A. K., Silvestri, G. A., Riley, T. L., Commins, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211776 · Cited by 1,029
Self-citationA calibration hierarchy for risk models was defined: from utopia to empirical data
Van Calster, B., Nieboer, D., Vergouwe, Y., De Cock, B., Pencina, M. J., & Steyerberg, E. W. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.12.005 · Cited by 910
Self-citationOverdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Patz, E. F., Pinsky, P., Gatsonis, C., Sicks, J. D., Kramer, B. S., Tammemägi, M. C., Chiles, C., Black, W. C., & Aberle, D. R. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12738 · Cited by 776
Self-citationCollins, G. S., Ogundimu, E. O., & Altman, D. G. (2016) · Statistics in Medicine · doi:10.1002/sim.6787 · Cited by 665
Oken, M. M., Hocking, W. G., Kvale, P. A., Andriole, G. L., Buys, S. S., Church, T. R., Crawford, E. D., Fouad, M. N., Isaacs, C., Reding, D. J., et al. (2011) · JAMA · doi:10.1001/jama.2011.1591 · Cited by 655
Variations in Lung Cancer Risk Among Smokers
Bach, P. B., Kattan, M. W., Thornquist, M. D., Kris, M. G., Tate, R. C., Barnett, M. J., Hsieh, L. J., & Begg, C. B. (2003) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.470 · Cited by 642
Vergouwe, Y., Steyerberg, E. W., Eijkemans, M. J. C., & Habbema, J. D. F. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.06.017 · Cited by 636
Self-citationvan der Heijden, G. J. M. G., T. Donders, A. R., Stijnen, T., & Moons, K. G. M. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.01.015 · Cited by 631
Jaklitsch, M. T., Jacobson, F. L., Austin, J. H. M., Field, J. K., Jett, J. R., Keshavjee, S., MacMahon, H., Mulshine, J. L., Munden, R. F., Salgia, R., et al. (2012) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.05.060 · Cited by 608
Debray, T. P. A., Vergouwe, Y., Koffijberg, H., Nieboer, D., Steyerberg, E. W., & Moons, K. G. M. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.06.018 · Cited by 597
Self-citationTargeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death
Kovalchik, S. A., Tammemagi, M., Berg, C. D., Caporaso, N. E., Riley, T. L., Korch, M., Silvestri, G. A., Chaturvedi, A. K., & Katki, H. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301851 · Cited by 575
Humphrey, L. L., Deffebach, M., Pappas, M., Baumann, C., Artis, K., Mitchell, J. P., Zakher, B., Fu, R., & Slatore, C. G. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-6-201309170-00690 · Cited by 534
Horeweg, N., van Rosmalen, J., Heuvelmans, M. A., van der Aalst, C. M., Vliegenthart, R., Scholten, E. T., ten Haaf, K., Nackaerts, K., Lammers, J.-W. J., Weenink, C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70389-4 · Cited by 526
Self-citationThe LLP risk model: an individual risk prediction model for lung cancer
Cassidy, A., Myles, J. P., van Tongeren, M., Page, R. D., Liloglou, T., Duffy, S. W., & Field, J. K. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604158 · Cited by 490
de Koning, H. J., Meza, R., Plevritis, S. K., ten Haaf, K., Munshi, V. N., Jeon, J., Erdogan, S. A., Kong, C. Y., Han, S. S., van Rosmalen, J., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2316 · Cited by 466
Self-citationA Risk Model for Prediction of Lung Cancer
Spitz, M. R., Hong, W. K., Amos, C. I., Wu, X., Schabath, M. B., Dong, Q., Shete, S., & Etzel, C. J. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk153 · Cited by 417
Tammemägi, M. C., Church, T. R., Hocking, W. G., Silvestri, G. A., Kvale, P. A., Riley, T. L., Commins, J., & Berg, C. D. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001764 · Cited by 358
Self-citationDevelopment and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening
Katki, H. A., Kovalchik, S. A., Berg, C. D., Cheung, L. C., & Chaturvedi, A. K. (2016) · JAMA · doi:10.1001/jama.2016.6255 · Cited by 338
Baseline Characteristics of Participants in the Randomized National Lung Screening Trial
The National Lung Screening Trial Research Team Writing committee:, Aberle, D. R., Adams, A. M., Berg, C. D., Clapp, J. D., Clingan, K. L., Gareen, I. F., Lynch, D. A., Marcus, P. M., & Pinsky, P. F. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq434 · Cited by 322
Comparisons of established risk prediction models for cardiovascular disease: systematic review
Siontis, G. C. M., Tzoulaki, I., Siontis, K. C., & Ioannidis, J. P. A. (2012) · BMJ · doi:10.1136/bmj.e3318 · Cited by 300
Vergouwe, Y., Moons, K. G. M., & Steyerberg, E. W. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq223 · Cited by 243
Self-citationHippisley-Cox, J., & Coupland, C. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x616355 · Cited by 208
Jolani, S., Debray, T. P. A., Koffijberg, H., van Buuren, S., & Moons, K. G. M. (2015) · Statistics in Medicine · doi:10.1002/sim.6451 · Cited by 192
Patz, E. F., Greco, E., Gatsonis, C., Pinsky, P., Kramer, B. S., & Aberle, D. R. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00621-x · Cited by 184
Raji, O. Y., Duffy, S. W., Agbaje, O. F., Baker, S. G., Christiani, D. C., Cassidy, A., & Field, J. K. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-4-201208210-00004 · Cited by 181
An Expanded Risk Prediction Model for Lung Cancer
Spitz, M. R., Etzel, C. J., Dong, Q., Amos, C. I., Wei, Q., Wu, X., & Hong, W. K. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0060 · Cited by 160
Etzioni, R., Gulati, R., Mallinger, L., & Mandelblatt, J. S. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-11-201306040-00008 · Cited by 139
McRonald, F. E., Yadegarfar, G., Baldwin, D., Devaraj, A., Brain, K. E., Eisen, T. G., Holemans, J. A., Ledson, M. J., Screaton, N. J., Rintoul, R. C., et al. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0206 · Cited by 127
Development and Validation of a Lung Cancer Risk Prediction Model for African-Americans
Etzel, C. J., Kachroo, S., Liu, M., D'amelio, A. M., Dong, Q., Coté, M. L., Wenzlaff, A. S., Hong, W. K., Greisinger, A. J., Schwartz, A. G., et al. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0082 · Cited by 125
Multistage Carcinogenesis and Lung Cancer Mortality in Three Cohorts
Hazelton, W. D., Clements, M., & Moolgavkar, S. H. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0756 · Cited by 122
A Risk Model for Lung Cancer Incidence
Hoggart, C. J., Brennan, P., Tjønneland, A. M., Vogel, U. B., Overvad, K., Østergaard, J. N., Kaaks, R., Canzian, F., Boeing, H., Steffen, A., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0237 · Cited by 120
Maisonneuve, P., Bagnardi, V., Bellomi, M., Spaggiari, L., Pelosi, G., Rampinelli, C., Bertolotti, R., Rotmensz, N., Field, J. K., DeCensi, A., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0026 · Cited by 119
Everything you always wanted to know about evaluating prediction models (but were too afraid to ask)
Vickers, A. J., & Cronin, A. M. (2010) · Urology · doi:10.1016/j.urology.2010.06.019 · Cited by 112
Comparing risk prediction models
Collins, G. S., & Moons, K. G. M. (2012) · BMJ · doi:10.1136/bmj.e3186 · Cited by 110
Bias arising from missing data in predictive models.
Gorelick, M. H. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.11.029 · Cited by 107
Li, K., Hüsing, A., Sookthai, D., Bergmann, M. M., Boeing, H., Becker, N., & Kaaks, R. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0424 · Cited by 107
Evaluation of a Personalized, Web-Based Decision Aid for Lung Cancer Screening
Lau, Y. K., Caverly, T. J., Cao, P., Cherng, S. T., West, M., Gaber, C. E., Arenberg, D. A., & Meza, R. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.07.027 · Cited by 100
Self-citationLung cancer screening: latest developments and unanswered questions
van der Aalst, C. M., ten Haaf, K., & de Koning, H. J. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30200-4 · Cited by 92
Hippisley‐Cox, J., & Coupland, C. A. C. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x606627 · Cited by 92
Screening High-Risk Populations for Lung Cancer: Guideline Recommendations
Roberts, H. C., Walker‐Dilks, C., Sivjee, K., Ung, Y., Yasufuku, K., Hey, A., & Lewis, N. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31829fd3d5 · Cited by 78
Iyen, B., Tata, L. J., Baldwin, D., Smith, C. J. P., & Hubbard, R. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202348 · Cited by 76
Comparison of discriminatory power and accuracy of three lung cancer risk models
D'amelio, A. M., Cassidy, A., Asomaning, K., Raji, O. Y., Duffy, S. W., Field, J. K., Spitz, M. R., Christiani, D. C., & Etzel, C. J. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605759 · Cited by 73
Individualized Risk Prediction Model for Lung Cancer in Korean Men
Park, S., Nam, B., Yang, H.-R., Lee, J. A., Lim, H., Han, J. T., Park, I. S., Shin, H., & Lee, J. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054823 · Cited by 70
Prediction of lung cancer risk in a Chinese population using a multifactorial genetic model
Li, H., Yang, L., Zhao, X., Wang, J., Qian, J., Chen, H., Fan, W., Liu, H., Li, J., Wang, W., et al. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-118 · Cited by 65
A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers
Young, R. P., Hopkins, R. J., Hay, B. A., Epton, M., Mills, G., Black, P., Gardner, H. D., Sullivan, R., & Gamble, G. D. (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.077107 · Cited by 63
El‐Zein, R. A., Lopez, M. S., D'amelio, A. M., Liu, M., Munden, R. F., Christiani, D. C., Su, L., Tejera, P., Zhai, R., Spitz, M. R., et al. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0462 · Cited by 48
Overdiagnosis in lung cancer screening: why modelling is essential
ten Haaf, K., & de Koning, H. J. (2015) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2014-204079 · Cited by 42
Steyerberg, E. W., Eijkemans, M. J. C., Boersma, E. H., & Habbema, J. D. F. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.07.008 · Cited by 29
Self-citationChapter 8: The FHCRC Lung Cancer Model
Hazelton, W. D., Jeon, J., Meza, R., & Moolgavkar, S. H. (2012) · Risk Analysis · doi:10.1111/j.1539-6924.2011.01681.x · Cited by 26
Self-citation
Cited by
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624
Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology
Wood, D. E., Kazerooni, E. A., Baum, S. L., Eapen, G. A., Ettinger, D. S., Hou, L., Jackman, D. M., Klippenstein, D., Kumar, R., Lackner, R. P., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0020 · Cited by 611
European position statement on lung cancer screening
Oudkerk, M., Devaraj, A., Vliegenthart, R., Henzler, T., Prosch, H., Heussel, C. P., Bastarrika, G., Sverzellati, N., Mascalchi, M., Delorme, S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30861-6 · Cited by 587
Self-citationBiomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
Seijo, L. M., Peled, N., Ajona, D., Boeri, M., Field, J. K., Sozzi, G., Pio, R., Zulueta, J. J., Spira, A., Massion, P. P., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.11.023 · Cited by 539
Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives
Oudkerk, M., Liu, S., Heuvelmans, M. A., Walter, J. E., & Field, J. K. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00432-6 · Cited by 519
Metadata
- Authors
- ten Haaf, K., Jeon, J., Tammemägi, M. C., Han, S. S., Kong, C. Y., Plevritis, S. K., Feuer, E. J., de Koning, H. J., Steyerberg, E. W., & Meza, R.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-04-04
- Volume
- 14
- Issue
- 4
- Pages
- e1002277
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2604950454
- Cited by
- 284
- References
- 70
- FWCI
- 23.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.